Hadjivassiliou Marios, Manto Mario, Mitoma Hiroshi
Academic Department of Neurosciences, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.
Service de Neurologie, Médiathèque Jean Jacquy, CHU-Charleroi, 6000 Charleroi, Belgium.
Brain Sci. 2022 Aug 30;12(9):1165. doi: 10.3390/brainsci12091165.
The cerebellum is particularly enriched in antigens and represents a vulnerable target to immune attacks. Immune-mediated cerebellar ataxias (IMCAs) have diverse etiologies, such as gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degeneration (PCD), opsoclonus myoclonus syndrome (OMS), and anti-GAD ataxia. Apart from these well-established entities, cerebellar ataxia (CA) occurs also in association with autoimmunity against ion channels and related proteins, synaptic adhesion/organizing proteins, transmitter receptors, glial cells, as well as the brainstem antigens. Most of these conditions manifest diverse neurological clinical features, with CAs being one of the main clinical phenotypes. The term primary autoimmune cerebellar ataxia (PACA) refers to ataxic conditions suspected to be autoimmune even in the absence of specific well-characterized pathogenic antibody markers. We review advances in the field of IMCAs and propose a clinical approach for the understanding and diagnosis of IMCAs, focusing on rare etiologies which are likely underdiagnosed. The frontiers of PACA are discussed. The identification of rare immune ataxias is of importance since they are potentially treatable and may lead to a severe clinical syndrome in absence of early therapy.
小脑富含抗原,是免疫攻击的易损靶点。免疫介导的小脑性共济失调(IMCA)病因多样,如麸质共济失调(GA)、感染后小脑炎(PIC)、米勒-费希尔综合征(MFS)、副肿瘤性小脑变性(PCD)、眼阵挛-肌阵挛综合征(OMS)和抗谷氨酸脱羧酶共济失调。除了这些已明确的疾病,小脑性共济失调(CA)也与针对离子通道及相关蛋白、突触黏附/组织蛋白、神经递质受体、神经胶质细胞以及脑干抗原的自身免疫有关。这些疾病大多表现出多样的神经临床特征,CA是主要临床表型之一。原发性自身免疫性小脑性共济失调(PACA)一词指即使在缺乏特定特征明确的致病性抗体标志物的情况下,也怀疑为自身免疫性的共济失调疾病。我们综述了IMCA领域的进展,并提出了一种理解和诊断IMCA的临床方法,重点关注可能诊断不足的罕见病因。讨论了PACA的前沿问题。识别罕见的免疫性共济失调很重要,因为它们有可能得到治疗,且在缺乏早期治疗的情况下可能导致严重的临床综合征。